ARTICLE | Company News
FDA panel to consider easing Lotronex REMS
July 8, 2013 11:34 PM UTC
FDA reviewers said the REMS with elements of safe use (ETASU) for irritable bowel syndrome drug Lotronex alosetron from Prometheus Laboratories Inc. is effective but may include a requirement that is ...